Skip to content
Screener

Ashland ASH Q3 2026 earnings

Reported July 28, 2026 · After market close

Revenue$497.0MBeat by $11.0M
Adjusted EPS$1.02Beat by $0.04
Revenue estimate$486.0M
EPS estimate$0.99
“Sales increased seven percent year-over-year, with growth achieved across all business units and regions. Our teams continued to successfully recover higher raw material costs through pricing actions, preserving margins while maintaining strong customer relationships. Life Sciences delivered double-digit sales gains, benefiting from broad demand across pharma and continued progress from our globalize and innovate strategies. Personal Care generated another quarter of strong performance, led by momentum in biofunctional actives, high-single-digit growth in skin care, and favorable contributions from hair care and microbial protection. Specialty Additives benefited from continued growth in coatings and performance specialties driven by share gains and strong commercial momentum. In Intermediates, merchant sales increased, reflecting improving NMP demand for battery-related applications.”
Guillermo Novo

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$502.4M
EPS estimate$1.32

Financials

Q3 2026

Income statement

See full
Revenue$497.0M+7.3%
Gross profit$170.0M+28.8%
Operating income$43.0M+106%
Net income$16.0M+102%
EPS (diluted)$0.35+102%

Balance sheet

See full
Cash & equivalents$440.0M+113%
Total debt$1.5B-0.6%
Total equity$1.9B-1.0%
Total assets$4.6B-0.9%

Cash flow

See full
Operating cash flow$120.0M+4.3%
CapEx$20.0M0.0%
Free cash flow$100.0M+5.3%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$3.23B+38.2%
Enterprise value$4.26B+18.0%
P/E161.4×—
P/S1.8×+0.5×

Profitability

See full
Gross margin31.5%+1.4pp
Operating margin4.1%—
Net margin1.1%+0.5pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity1.1%+0.5pp
Debt / equity0.8×0.0×
Current ratio3×+0.4×

Segments

By segment

See full
Life Sciences$180.0M+11.1%
Personal Care And Household$155.0M+5.4%
Specialty Additives$136.0M+3.8%
Intermediates And Solvents$37.0M+12.1%

By geography

See full
Europe$185.0M+5.1%
North America$144.0M+7.5%
Asia Pacific$132.0M+11.9%
Latin America And Other$47.0M+4.4%

FAQ

When did Ashland report Q3 2026 earnings?
Ashland (ASH) reported Q3 2026 earnings on July 28, 2026 after market close.
What were Ashland's Q3 2026 revenue and EPS?
Ashland reported revenue of $497.0M and adjusted eps of $1.02 for Q3 2026.
Did Ashland beat estimates in Q3 2026?
Revenue beat the consensus estimate of $486.0M by $11.0M. EPS beat the consensus estimate of $0.98 by $0.04.
How did Ashland's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.3% from $463.0M a year earlier.
Where can I find Ashland's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-321238) and the 10-Q periodic report (0001193125-26-324226) directly on SEC EDGAR. The filing index links above go to sec.gov.